ИНФОРМАЦИЯ ДЛЯ СПЕЦИАЛИСТОВ ЗДРАВООХРАНЕНИЯ
Информация на данном сайте содержит специализированную медицинскую информацию, предназначенную только для дипломированных специалистов здравоохранения. Продолжая использовать данный сайт, вы подтверждаете, что являетесь специалистом здравоохранения.

ИСПОЛЬЗОВАННАЯ ЛИТЕРАТУРА

1. Gerritsen J., et al. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 6:209-240.
2. Distrutti E, et al. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 2016;21;22(7): 2219-41.
3. Bull MJ, Plummer NT. Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas) 2014;13(6):17-22.
4. McCarville JL, et al. Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol 2016;9(4): 580-93.
5. IBS in American survey – oct 2015 conducted by the American Gastroenterological Association.
6. Enck P., et al. Irritable Bowel Syndrome. Nat Rev Dis Primers 2016 2 :16014.
7. Canavan C, et al. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023-34.
8. Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol 2016;9(3):354-75.
9. Общие рекомендации Всемирной гастроэнтерологической организации. Синдром раздраженного кишечника. 2015.
10. Lacy B.E., et al. Bowel Disorders. Gastroenterology 2016;150:1393-1407.
11. Ducrotté P. Microbiota and functional gastrointestinal disorders. In Marteau P., Doré J (coord). Gut Microbiota, A full-fledged organ. Paris : John LibbeyEurotext, 2017, chapter 12, p.113-24.
12. Hod K, Ringel Y. Probiotics in functional bowel disorders. Best Pract Res Clin Gastroenterol 2016;30(1):89-97.
13. Farzaei MH, et al. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil 2016;22(4):558-74.
14. Mertz H., et al. Altered Rectal Perception is a Biological Marker of Patients With Irritable Bowel Syndrome. Gastroenterology 1995;109:40-52.
15. Ohman L., et al. Pathogenesis of IBS : role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 7,163-173 (2010).
16. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behavior. Nat Rev Neurosci 2012;13(10):701-12.
17. Bharucha AE, et al. Common Functional Gastroenterological Disorders Associated With Abdominal Pain. Mayo Clin Proc 2016;91(8):1118-32.
18. https://patient.info/health/irritable-bowel-syndrome-diet-sheet, дата обращения: 2017/05/12.
19. Johannesson E, Ringström G, Abrahamsson H, et al. Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects. World J Gastroenterol 2015;21(2):600-8.
20. Tack J., et al. Modern Management of Irritable Bowel Syndrome : More than Motility. Dig Dis 2016;34:566-573.
21. Bull MJ, Plummer NT. Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis. Integr Med (Encinitas) 2015;14(1): 25-33.
22. Общие рекомендации Всемирной гастроэнтерологической организации. Пробиотики и пребиотики. 2017.
23. O'Mahony L, et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 2006;290(4):G839-45.
24. O'Hara AM, et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006;118(2):202-15.
25. Konieczna P, et al. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2012;61:354-66.
26. O'Mahony L, et al. Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome: Symptom Responses and Relationship to Cytokine Profiles. Gastroenterology 2005;128:541-51.
27. Whorwell PJ, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Am J Gastroenterol 2006;101(7):1581-90.
Материал не является рекламой, публикуется как монография и отражает мнение медицинских специалистов